Author | Guedes, Paulo Marcos Matta | |
Author | Gutierrez, Fredy Roberto Salazar | |
Author | Nascimento, Manuela Sales Lima | |
Author | Matta, Maria Adelaide do Valle | |
Author | Silva, João Santana | |
Access date | 2017-05-11T11:11:29Z | |
Available date | 2017-05-11T11:11:29Z | |
Document date | 2012 | |
Citation | GUEDES, Paulo Marcos Matta; et al. Antiparasitical chemotherapy in Chagas’ disease cardiomyopathy: current evidence. Tropical Medicine and International Health, v.17, n.9, p.1057-1065, Sept. 2012. | pt_BR |
ISSN | 1360-2276 | pt_BR |
URI | https://www.arca.fiocruz.br/handle/icict/18807 | |
Language | eng | pt_BR |
Publisher | Wiley | pt_BR |
Rights | restricted access | pt_BR |
Subject in Portuguese | Trypanosoma cruzi | pt_BR |
Subject in Portuguese | Doença de Chagas | pt_BR |
Subject in Portuguese | Quimioterapia | pt_BR |
Subject in Portuguese | Persistência do parasita | pt_BR |
Subject in Portuguese | Inflamação cardíaca | pt_BR |
Title | Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence | pt_BR |
Type | Article | pt_BR |
DOI | 10.1111/j.1365-3156.2012.03025.x | |
Abstract | Chronic chagasic cardiomyopathy affects 20% of Chagas' disease patients. At present, Chagas' disease chemotherapy uses nitrofurans, benznidazole (Rochagan®, Rodanil®, Roche) or nifurtimox (Lampit®, Bayer). Treatment during acute and recent chronic phases in childhood effects 71.5% and 57.6%, respectively, of parasitological cure. However, in clinical trials during the late chronic phase, only 5.9% of parasitological cure were achieved. This review focuses on the benefit from aetiological treatment to avoid, stop or revert myocarditis. Divergent data gathered from clinical practice are not convincing to support prescription of aetiological treatment as routine for indeterminate and cardiac chronic patients. | pt_BR |
Affilliation | Universidade Federal do Rio Grande do Norte. Centro de Biociências. Departamento de Microbiologia e Parasitologia. Natal, RN, Brasil. | pt_BR |
Affilliation | University Antonio Nariño. School of Medicine. Bogotá, Colombia. | pt_BR |
Affilliation | Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Departamento de Bioquímica e Imunologia. Ribeirão Preto, SP, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Ultraestrutura Celular. Rio de Janeiro, RJ. Brasil. | pt_BR |
Affilliation | Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Departamento de Bioquímica e Imunologia. Ribeirão Preto, SP, Brasil. | pt_BR |
Subject | Trypanosoma cruzi | pt_BR |
Subject | Chagas Disease | pt_BR |
Subject | chemotherapy | pt_BR |
Subject | parasite persistence | pt_BR |
Subject | cardiac inflammation | pt_BR |
e-ISSN | 1365-3156 | |
Embargo date | 2030-01-01 | |